Targeting INHBA in Ovarian Cancer Cells Suppresses Cancer Xenograft Growth by Attenuating Stromal Fibroblast Activation

Table 1

Association of INHBA expression with the clinicopathological variables of primary SOC patients (132^a cases).

Variable	INHBA expression
	Low	High	Total
Age^a
≤50 years	29	18	47
>50 years	56	27	83
Stage^a
I	81	31	112
II	4	4	8
III	0	6	6
IV	0	4	4
Grade^b
1	23	4	27
2	9	4	13
3	51	36	87

^aTwo cases without epithelial components were excluded. ^bFive cases without grade information were excluded.